Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nephrology | 18 | 2024 | 263 | 5.900 |
Why?
|
Renal Dialysis | 32 | 2024 | 1786 | 4.370 |
Why?
|
Kidney Failure, Chronic | 25 | 2024 | 2538 | 4.270 |
Why?
|
Kidney Diseases | 16 | 2024 | 2149 | 3.510 |
Why?
|
Peritoneal Dialysis | 7 | 2023 | 146 | 3.230 |
Why?
|
Renal Insufficiency, Chronic | 16 | 2023 | 2208 | 3.000 |
Why?
|
Nephrons | 10 | 2023 | 220 | 2.560 |
Why?
|
Kidney | 27 | 2024 | 7186 | 2.330 |
Why?
|
Acute Kidney Injury | 19 | 2024 | 1972 | 1.920 |
Why?
|
Premature Birth | 4 | 2023 | 1721 | 1.300 |
Why?
|
Renal Replacement Therapy | 7 | 2021 | 257 | 1.270 |
Why?
|
Birth Weight | 6 | 2019 | 2069 | 1.030 |
Why?
|
Longevity | 2 | 2023 | 1070 | 1.000 |
Why?
|
Fetal Development | 3 | 2019 | 767 | 0.990 |
Why?
|
Medicine, Traditional | 3 | 2012 | 91 | 0.950 |
Why?
|
Shiga-Toxigenic Escherichia coli | 1 | 2023 | 28 | 0.940 |
Why?
|
Ethics, Research | 3 | 2021 | 191 | 0.910 |
Why?
|
Glomerular Filtration Rate | 8 | 2023 | 2170 | 0.910 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2023 | 110 | 0.900 |
Why?
|
Hypertension | 9 | 2024 | 8480 | 0.890 |
Why?
|
Kidney Transplantation | 11 | 2023 | 4251 | 0.870 |
Why?
|
Health Services Accessibility | 10 | 2022 | 5137 | 0.870 |
Why?
|
Renal Insufficiency | 3 | 2023 | 804 | 0.860 |
Why?
|
Health Care Rationing | 2 | 2021 | 437 | 0.750 |
Why?
|
Infant, Low Birth Weight | 6 | 2017 | 850 | 0.740 |
Why?
|
Medicine, African Traditional | 3 | 2005 | 29 | 0.710 |
Why?
|
Escherichia coli Infections | 1 | 2023 | 532 | 0.700 |
Why?
|
Africa South of the Sahara | 5 | 2022 | 724 | 0.670 |
Why?
|
Disasters | 6 | 2023 | 511 | 0.670 |
Why?
|
Voice | 1 | 2022 | 259 | 0.670 |
Why?
|
Health Resources | 6 | 2020 | 911 | 0.650 |
Why?
|
Social Responsibility | 2 | 2021 | 389 | 0.640 |
Why?
|
Plant Preparations | 2 | 2012 | 94 | 0.600 |
Why?
|
Developing Countries | 12 | 2023 | 2815 | 0.590 |
Why?
|
Conservation of Natural Resources | 1 | 2018 | 204 | 0.540 |
Why?
|
Humans | 106 | 2024 | 744343 | 0.530 |
Why?
|
Transients and Migrants | 1 | 2017 | 155 | 0.510 |
Why?
|
Refugees | 2 | 2023 | 511 | 0.510 |
Why?
|
Stromal Cells | 1 | 2020 | 1355 | 0.480 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1200 | 0.480 |
Why?
|
Gestational Age | 3 | 2017 | 3493 | 0.470 |
Why?
|
Infant, Small for Gestational Age | 1 | 2016 | 440 | 0.460 |
Why?
|
Epidemics | 1 | 2019 | 523 | 0.450 |
Why?
|
Goals | 1 | 2018 | 706 | 0.430 |
Why?
|
Health Status Disparities | 1 | 2023 | 1797 | 0.410 |
Why?
|
Health Expenditures | 5 | 2020 | 2348 | 0.410 |
Why?
|
Pandemics | 9 | 2024 | 8388 | 0.400 |
Why?
|
Living Donors | 3 | 2015 | 620 | 0.390 |
Why?
|
Martial Arts | 1 | 2011 | 27 | 0.390 |
Why?
|
Healthcare Disparities | 3 | 2023 | 3158 | 0.380 |
Why?
|
Self Medication | 1 | 2011 | 117 | 0.370 |
Why?
|
Delivery of Health Care | 5 | 2023 | 5319 | 0.360 |
Why?
|
Acute-Phase Reaction | 2 | 2010 | 91 | 0.360 |
Why?
|
Chloride Channels | 3 | 2000 | 227 | 0.350 |
Why?
|
Oncostatin M Receptor beta Subunit | 1 | 2009 | 4 | 0.350 |
Why?
|
Aging, Premature | 1 | 2009 | 47 | 0.350 |
Why?
|
Disease Management | 2 | 2017 | 2459 | 0.340 |
Why?
|
Infant, Newborn | 12 | 2023 | 25625 | 0.340 |
Why?
|
Oncostatin M | 1 | 2009 | 28 | 0.340 |
Why?
|
Child Welfare | 1 | 2013 | 523 | 0.330 |
Why?
|
Malnutrition | 1 | 2015 | 625 | 0.320 |
Why?
|
Complementary Therapies | 1 | 2012 | 486 | 0.310 |
Why?
|
Biomedical Research | 2 | 2021 | 3309 | 0.310 |
Why?
|
Tendon Injuries | 1 | 2011 | 313 | 0.300 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2019 | 2408 | 0.290 |
Why?
|
Decision Making | 2 | 2020 | 3887 | 0.290 |
Why?
|
Kidney Tubules | 1 | 2009 | 488 | 0.280 |
Why?
|
Endocarditis, Bacterial | 1 | 2011 | 455 | 0.280 |
Why?
|
Physicians | 3 | 2023 | 4567 | 0.270 |
Why?
|
Africa | 2 | 2022 | 673 | 0.270 |
Why?
|
Human Growth Hormone | 1 | 2011 | 683 | 0.260 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 1312 | 0.260 |
Why?
|
South Africa | 7 | 2024 | 1731 | 0.260 |
Why?
|
Child | 15 | 2024 | 77709 | 0.260 |
Why?
|
Internationality | 2 | 2020 | 1003 | 0.250 |
Why?
|
Red Cross | 1 | 2024 | 13 | 0.250 |
Why?
|
Shiga Toxins | 1 | 2023 | 41 | 0.240 |
Why?
|
Animals, Newborn | 1 | 2009 | 2726 | 0.240 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2005 | 113 | 0.230 |
Why?
|
Malaria | 2 | 2024 | 1239 | 0.230 |
Why?
|
Androgens | 1 | 2011 | 1281 | 0.230 |
Why?
|
Phytotherapy | 2 | 2003 | 298 | 0.220 |
Why?
|
Arteriovenous Shunt, Surgical | 2 | 2023 | 277 | 0.220 |
Why?
|
Uremia | 1 | 2024 | 201 | 0.220 |
Why?
|
Adult | 22 | 2024 | 214055 | 0.220 |
Why?
|
Aloe | 1 | 2002 | 2 | 0.210 |
Why?
|
Poverty | 3 | 2020 | 2660 | 0.210 |
Why?
|
Health Priorities | 2 | 2017 | 380 | 0.210 |
Why?
|
Consensus | 3 | 2014 | 2959 | 0.190 |
Why?
|
Risk Factors | 12 | 2024 | 72290 | 0.190 |
Why?
|
Catastrophic Illness | 1 | 2020 | 57 | 0.180 |
Why?
|
Dietary Proteins | 2 | 2008 | 963 | 0.180 |
Why?
|
Kidney Calculi | 1 | 2004 | 465 | 0.180 |
Why?
|
Carbon | 1 | 2023 | 687 | 0.180 |
Why?
|
Pregnancy | 6 | 2023 | 29144 | 0.180 |
Why?
|
Ethics Committees, Research | 1 | 2021 | 194 | 0.170 |
Why?
|
Nephritis, Interstitial | 1 | 2021 | 156 | 0.170 |
Why?
|
Central America | 1 | 2019 | 68 | 0.170 |
Why?
|
Masks | 1 | 2022 | 197 | 0.170 |
Why?
|
Sri Lanka | 1 | 2019 | 90 | 0.170 |
Why?
|
Morals | 1 | 2022 | 284 | 0.170 |
Why?
|
Critical Illness | 4 | 2020 | 2670 | 0.170 |
Why?
|
Policy | 1 | 2023 | 508 | 0.170 |
Why?
|
Long-Term Care | 1 | 2023 | 607 | 0.170 |
Why?
|
Early Diagnosis | 2 | 2020 | 1184 | 0.160 |
Why?
|
Relief Work | 2 | 2010 | 137 | 0.160 |
Why?
|
Kidney Cortex | 1 | 1998 | 186 | 0.160 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 3229 | 0.160 |
Why?
|
Organ Size | 2 | 2016 | 2252 | 0.160 |
Why?
|
Female | 24 | 2023 | 380194 | 0.160 |
Why?
|
Climate Change | 1 | 2023 | 418 | 0.160 |
Why?
|
Wounds and Injuries | 3 | 2014 | 2400 | 0.150 |
Why?
|
Earthquakes | 2 | 2010 | 179 | 0.150 |
Why?
|
Europe | 3 | 2020 | 3339 | 0.150 |
Why?
|
Male | 27 | 2023 | 350118 | 0.150 |
Why?
|
Education | 1 | 2020 | 543 | 0.150 |
Why?
|
Conflict of Interest | 1 | 2022 | 544 | 0.150 |
Why?
|
Health Planning | 1 | 2019 | 238 | 0.150 |
Why?
|
Cystatin C | 2 | 2016 | 250 | 0.150 |
Why?
|
Research Support as Topic | 1 | 2021 | 705 | 0.140 |
Why?
|
Blood Pressure | 3 | 2019 | 8554 | 0.140 |
Why?
|
Hypertension, Renal | 1 | 2017 | 177 | 0.140 |
Why?
|
Social Justice | 1 | 2020 | 456 | 0.140 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 711 | 0.130 |
Why?
|
Term Birth | 1 | 2016 | 135 | 0.130 |
Why?
|
Sex Factors | 3 | 2022 | 10397 | 0.130 |
Why?
|
Infant, Premature | 2 | 2017 | 2044 | 0.130 |
Why?
|
Ethics, Medical | 1 | 2021 | 792 | 0.130 |
Why?
|
Malaria, Falciparum | 1 | 2024 | 1077 | 0.130 |
Why?
|
Health Planning Organizations | 1 | 2014 | 12 | 0.130 |
Why?
|
Hospitals, Pediatric | 1 | 2024 | 1775 | 0.130 |
Why?
|
Primary Graft Dysfunction | 1 | 2015 | 93 | 0.120 |
Why?
|
Child, Preschool | 6 | 2023 | 41006 | 0.120 |
Why?
|
Violence | 1 | 2020 | 909 | 0.120 |
Why?
|
Disease Outbreaks | 1 | 2024 | 1772 | 0.120 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1125 | 0.120 |
Why?
|
Triage | 1 | 2020 | 976 | 0.110 |
Why?
|
Cardiovascular Diseases | 2 | 2009 | 15165 | 0.110 |
Why?
|
Maternal Age | 1 | 2016 | 802 | 0.110 |
Why?
|
Graft Survival | 3 | 2021 | 3737 | 0.110 |
Why?
|
Herb-Drug Interactions | 1 | 2012 | 10 | 0.110 |
Why?
|
Maternal Welfare | 1 | 2013 | 115 | 0.110 |
Why?
|
Health Policy | 3 | 2020 | 2661 | 0.110 |
Why?
|
Morbidity | 1 | 2018 | 1769 | 0.110 |
Why?
|
Health Services Needs and Demand | 2 | 2017 | 1411 | 0.110 |
Why?
|
Capacity Building | 1 | 2014 | 248 | 0.100 |
Why?
|
Developed Countries | 3 | 2020 | 437 | 0.100 |
Why?
|
Creatinine | 2 | 2015 | 1919 | 0.100 |
Why?
|
Urea | 2 | 2024 | 450 | 0.100 |
Why?
|
Rats | 4 | 2020 | 24260 | 0.100 |
Why?
|
Proteinuria | 2 | 2013 | 658 | 0.100 |
Why?
|
Delayed Graft Function | 1 | 2011 | 48 | 0.100 |
Why?
|
Drug Contamination | 1 | 2012 | 147 | 0.100 |
Why?
|
Critical Care | 4 | 2020 | 2647 | 0.090 |
Why?
|
Renal Colic | 1 | 2011 | 31 | 0.090 |
Why?
|
Crush Syndrome | 1 | 2010 | 8 | 0.090 |
Why?
|
Renal Artery | 1 | 2012 | 398 | 0.090 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 2009 | 46 | 0.090 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2011 | 126 | 0.090 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2013 | 378 | 0.090 |
Why?
|
Body Height | 1 | 2016 | 1577 | 0.090 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7785 | 0.090 |
Why?
|
Prenatal Care | 1 | 2017 | 1092 | 0.090 |
Why?
|
Rupture | 1 | 2011 | 433 | 0.090 |
Why?
|
Parathyroidectomy | 1 | 2011 | 235 | 0.080 |
Why?
|
Tuberculosis | 1 | 2021 | 1912 | 0.080 |
Why?
|
Regional Blood Flow | 1 | 2012 | 1525 | 0.080 |
Why?
|
Fetal Growth Retardation | 1 | 2012 | 570 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4751 | 0.080 |
Why?
|
Calcinosis | 1 | 2017 | 1499 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3218 | 0.080 |
Why?
|
alpha 1-Antitrypsin | 1 | 2009 | 164 | 0.080 |
Why?
|
Cystatins | 1 | 2008 | 55 | 0.080 |
Why?
|
Heart Function Tests | 1 | 2009 | 330 | 0.080 |
Why?
|
Age Factors | 3 | 2012 | 18370 | 0.080 |
Why?
|
Chronic Disease | 3 | 2013 | 9146 | 0.080 |
Why?
|
Acute-Phase Proteins | 1 | 2009 | 262 | 0.080 |
Why?
|
Macrophage Activation | 1 | 2010 | 558 | 0.080 |
Why?
|
Graft Rejection | 2 | 2011 | 4397 | 0.080 |
Why?
|
Receptors, Interleukin-6 | 1 | 2009 | 224 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2021 | 3679 | 0.080 |
Why?
|
Oxidoreductases | 1 | 2009 | 424 | 0.070 |
Why?
|
Cost Sharing | 2 | 2020 | 407 | 0.070 |
Why?
|
Mortality | 1 | 2018 | 2864 | 0.070 |
Why?
|
Nephrectomy | 1 | 2012 | 1050 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2009 | 705 | 0.070 |
Why?
|
Calcium | 1 | 1999 | 5756 | 0.070 |
Why?
|
Population Surveillance | 1 | 2017 | 2616 | 0.070 |
Why?
|
Adolescent | 7 | 2024 | 85781 | 0.070 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 25043 | 0.070 |
Why?
|
Tissue Donors | 1 | 2015 | 2240 | 0.070 |
Why?
|
Research | 1 | 2014 | 1999 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7279 | 0.070 |
Why?
|
Retinoblastoma Protein | 1 | 2009 | 704 | 0.070 |
Why?
|
Signal Transduction | 1 | 2009 | 23403 | 0.070 |
Why?
|
Fibrinogen | 1 | 2009 | 894 | 0.070 |
Why?
|
Energy Intake | 2 | 2010 | 2148 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13989 | 0.060 |
Why?
|
Costs and Cost Analysis | 2 | 2020 | 1681 | 0.060 |
Why?
|
Hemodialysis, Home | 1 | 2024 | 21 | 0.060 |
Why?
|
Health Care Costs | 1 | 2017 | 3209 | 0.060 |
Why?
|
Enema | 1 | 2004 | 141 | 0.060 |
Why?
|
Sudan | 1 | 2023 | 83 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3920 | 0.060 |
Why?
|
Infant | 3 | 2016 | 35136 | 0.060 |
Why?
|
Ukraine | 1 | 2023 | 111 | 0.060 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2009 | 859 | 0.060 |
Why?
|
Ultrasonography | 1 | 2016 | 5985 | 0.060 |
Why?
|
Weight Gain | 1 | 2013 | 2292 | 0.050 |
Why?
|
Chromones | 1 | 2003 | 154 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1917 | 0.050 |
Why?
|
Liver Failure | 1 | 2005 | 241 | 0.050 |
Why?
|
Young Adult | 3 | 2021 | 56430 | 0.050 |
Why?
|
Ghana | 1 | 2023 | 286 | 0.050 |
Why?
|
Peritoneum | 1 | 2023 | 228 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3605 | 0.050 |
Why?
|
Diabetic Nephropathies | 2 | 2008 | 984 | 0.050 |
Why?
|
Plants, Medicinal | 1 | 2003 | 167 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 12804 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 2 | 2012 | 8301 | 0.050 |
Why?
|
Comorbidity | 2 | 2009 | 10388 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2077 | 0.050 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2000 | 1085 | 0.050 |
Why?
|
Switzerland | 1 | 2022 | 255 | 0.050 |
Why?
|
Child Development | 1 | 2013 | 2223 | 0.050 |
Why?
|
Tea | 1 | 2003 | 275 | 0.050 |
Why?
|
Australasia | 1 | 2020 | 19 | 0.050 |
Why?
|
Catheters, Indwelling | 1 | 2023 | 426 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18029 | 0.050 |
Why?
|
Ethical Analysis | 1 | 2020 | 42 | 0.050 |
Why?
|
Research Design | 1 | 2016 | 5987 | 0.050 |
Why?
|
Iatrogenic Disease | 1 | 2024 | 547 | 0.050 |
Why?
|
Orthopedic Procedures | 1 | 2011 | 1288 | 0.050 |
Why?
|
Paracrine Communication | 1 | 2002 | 277 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17446 | 0.050 |
Why?
|
Isoniazid | 1 | 2021 | 274 | 0.040 |
Why?
|
Animals | 8 | 2020 | 168757 | 0.040 |
Why?
|
RNA, Catalytic | 1 | 1999 | 50 | 0.040 |
Why?
|
Transportation of Patients | 1 | 2020 | 185 | 0.040 |
Why?
|
Prevalence | 2 | 2023 | 15226 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15295 | 0.040 |
Why?
|
Middle Aged | 10 | 2023 | 213383 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2013 | 2861 | 0.040 |
Why?
|
Administrative Personnel | 1 | 2020 | 187 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2015 | 63114 | 0.040 |
Why?
|
Epidemiologic Methods | 1 | 2004 | 1364 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2009 | 3200 | 0.040 |
Why?
|
Asia | 1 | 2020 | 610 | 0.040 |
Why?
|
Glucosides | 1 | 2003 | 451 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9583 | 0.040 |
Why?
|
Electrolytes | 1 | 1999 | 282 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2010 | 2899 | 0.040 |
Why?
|
Kidney Tubules, Proximal | 1 | 2000 | 416 | 0.040 |
Why?
|
Granuloma | 1 | 2021 | 319 | 0.040 |
Why?
|
Glomerulonephritis | 1 | 2020 | 372 | 0.040 |
Why?
|
Fetus | 1 | 2006 | 1880 | 0.040 |
Why?
|
Cause of Death | 1 | 2009 | 3584 | 0.040 |
Why?
|
Haiti | 2 | 2010 | 553 | 0.040 |
Why?
|
Gene Expression | 2 | 2009 | 7799 | 0.040 |
Why?
|
Body Mass Index | 2 | 2013 | 12720 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2009 | 3768 | 0.040 |
Why?
|
Syndrome | 1 | 2024 | 3251 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2020 | 261 | 0.040 |
Why?
|
Health Occupations | 1 | 2019 | 224 | 0.040 |
Why?
|
Constipation | 1 | 2002 | 546 | 0.040 |
Why?
|
Diet | 2 | 2009 | 7939 | 0.040 |
Why?
|
Chemokine CCL2 | 1 | 1999 | 617 | 0.040 |
Why?
|
Biopsy | 1 | 2009 | 6756 | 0.040 |
Why?
|
Patient Advocacy | 1 | 2019 | 353 | 0.040 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2020 | 427 | 0.040 |
Why?
|
Myocardium | 1 | 2009 | 4776 | 0.030 |
Why?
|
Aged | 4 | 2023 | 163280 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2011 | 9438 | 0.030 |
Why?
|
Risk Assessment | 1 | 2017 | 23338 | 0.030 |
Why?
|
Echocardiography | 1 | 2009 | 5102 | 0.030 |
Why?
|
Stroke Volume | 1 | 2009 | 5007 | 0.030 |
Why?
|
Liver Diseases | 1 | 2004 | 1253 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 5021 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2065 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2009 | 19229 | 0.030 |
Why?
|
Quality of Health Care | 2 | 2020 | 4371 | 0.030 |
Why?
|
Renin-Angiotensin System | 1 | 1999 | 759 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 1998 | 1950 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 3658 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2024 | 77449 | 0.030 |
Why?
|
Competency-Based Education | 1 | 2016 | 211 | 0.030 |
Why?
|
Base Sequence | 3 | 2000 | 12797 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5078 | 0.030 |
Why?
|
Biomedical Technology | 1 | 2016 | 220 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2021 | 1320 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1999 | 1116 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2017 | 764 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2011 | 13033 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 10943 | 0.030 |
Why?
|
Phenylephrine | 1 | 2012 | 301 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1375 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 500 | 0.020 |
Why?
|
Prospective Studies | 3 | 2024 | 53288 | 0.020 |
Why?
|
Maps as Topic | 1 | 2010 | 17 | 0.020 |
Why?
|
Neopterin | 1 | 2010 | 56 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2010 | 7659 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15540 | 0.020 |
Why?
|
Choline | 1 | 2012 | 493 | 0.020 |
Why?
|
Serum Amyloid A Protein | 1 | 2010 | 121 | 0.020 |
Why?
|
Aging | 1 | 2009 | 8664 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2009 | 19905 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3176 | 0.020 |
Why?
|
Kidney Glomerulus | 2 | 2006 | 697 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 840 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 40561 | 0.020 |
Why?
|
Chile | 1 | 2010 | 237 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 12745 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 18111 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 183 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4456 | 0.020 |
Why?
|
Models, Genetic | 1 | 1999 | 3494 | 0.020 |
Why?
|
Drug Discovery | 1 | 2017 | 1058 | 0.020 |
Why?
|
Quality Improvement | 1 | 2024 | 3749 | 0.020 |
Why?
|
Body Weight | 1 | 1999 | 4669 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10252 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3743 | 0.020 |
Why?
|
HIV Infections | 2 | 2005 | 16718 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5391 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4149 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 1999 | 9734 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2005 | 5751 | 0.020 |
Why?
|
Survival Rate | 2 | 2011 | 12788 | 0.020 |
Why?
|
Oligosaccharides | 1 | 2008 | 414 | 0.020 |
Why?
|
Apoptosis | 1 | 2002 | 9727 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2008 | 684 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1439 | 0.020 |
Why?
|
Anthropometry | 1 | 2010 | 1350 | 0.020 |
Why?
|
Rest | 1 | 2010 | 901 | 0.020 |
Why?
|
Genotype | 1 | 1999 | 12951 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 1998 | 11366 | 0.020 |
Why?
|
Education, Medical | 1 | 2016 | 1721 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 35421 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2012 | 2132 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2291 | 0.010 |
Why?
|
International Cooperation | 1 | 2010 | 1420 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20947 | 0.010 |
Why?
|
Eating | 1 | 2010 | 1536 | 0.010 |
Why?
|
Reference Values | 1 | 2010 | 4982 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 4776 | 0.010 |
Why?
|
Culture Media, Serum-Free | 1 | 2002 | 158 | 0.010 |
Why?
|
Phenotype | 1 | 1999 | 16365 | 0.010 |
Why?
|
Cytoprotection | 1 | 2002 | 210 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7913 | 0.010 |
Why?
|
LLC-PK1 Cells | 1 | 2000 | 132 | 0.010 |
Why?
|
Biological Factors | 1 | 2002 | 164 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2002 | 537 | 0.010 |
Why?
|
Body Composition | 1 | 2010 | 2401 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13284 | 0.010 |
Why?
|
Clinical Competence | 1 | 2016 | 4687 | 0.010 |
Why?
|
Prognosis | 2 | 2011 | 29063 | 0.010 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 1999 | 67 | 0.010 |
Why?
|
Vomiting | 1 | 2003 | 636 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15076 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2011 | 39050 | 0.010 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 1999 | 152 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2003 | 1572 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3778 | 0.010 |
Why?
|
Xenopus | 1 | 2000 | 712 | 0.010 |
Why?
|
Molecular Structure | 1 | 2003 | 1899 | 0.010 |
Why?
|
Enalapril | 1 | 1999 | 327 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2000 | 2050 | 0.010 |
Why?
|
Growth Substances | 1 | 1999 | 784 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2002 | 1227 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1999 | 1901 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2003 | 2203 | 0.010 |
Why?
|
Biphenyl Compounds | 1 | 1999 | 913 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4320 | 0.010 |
Why?
|
DNA Primers | 1 | 1999 | 2892 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2002 | 1351 | 0.010 |
Why?
|
Benzimidazoles | 1 | 1999 | 850 | 0.010 |
Why?
|
Tetrazoles | 1 | 1999 | 835 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40075 | 0.010 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 1999 | 924 | 0.010 |
Why?
|
Blood Glucose | 1 | 2008 | 6256 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1999 | 1518 | 0.010 |
Why?
|
Mice | 1 | 1999 | 81183 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2003 | 3760 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2010 | 21746 | 0.010 |
Why?
|
Cell Survival | 1 | 2002 | 5882 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2002 | 2948 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3798 | 0.010 |
Why?
|
Swine | 1 | 2000 | 5917 | 0.010 |
Why?
|
Mitochondria | 1 | 2002 | 3520 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13815 | 0.010 |
Why?
|
Macrophages | 1 | 1999 | 5655 | 0.000 |
Why?
|
Cytokines | 1 | 1999 | 7322 | 0.000 |
Why?
|